Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (DL38433)

This document is an administrative response to comments regarding the MolDX Decipher® prostate cancer genomic classifier LCD (L38433), noting a title revision to “MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease” and providing comment and effective dates. The provided text contains no coverage, medical necessity, or billing criteria; reviewers must consult LCD L38433 for the actual coverage indications, limitations, documentation, and frequency rules.